ScripsAmerica Prepays $50,000 Convertible Promissory Note

TYSONS CORNER, Va., March 31, 2014 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced the prepayment of an outstanding convertible note in the principal amount of $50,000.

On April 22, 2014, $51,732 due under the one-year note issued to the Company by LG Capital which includes principal and interest, becomes convertible into shares of ScripsAmerica's common stock at a specified discount. The Company's cash payment has rendered its outstanding promissory note to LG Capital paid in full prior to its eligibility date for conversion into common stock.

The debt prepayment was funded by ScripsAmerica's cash on hand resulting from revenue generated by its business operations including a pharmaceutical equity venture with WholesaleRx and the specialty pharmacy that Scrips manages.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: 888-959-7095 ir@sealpointconsulting.comSource:ScripsAmerica, Inc.